Quarterly Report • Aug 31, 2011
Quarterly Report
Open in ViewerOpens in native device viewer
In the first half of the financial year the NAV fell from 107.92 pence to 93.84 pence, a fall of 10.3% taking into account the 3 pence dividend distribution in July 2011. During the same period the FTSE AIM All Share Index fell by 17.0%, which whilst the only sensible benchmark, is not wholly comparable as it is has a high proportion of large mining and commodities stocks in which a VCT cannot invest.
At 31 August 2011 the NAV was 93.84 pence which after adjusting for the dividends paid gives a total return of 112.84 pence. The loss per ordinary share for the six month period was 11.06 pence per share (comprising revenue losses of 1.27 pence and capital losses of 9.79 pence).
The Investment Manager, Hargreave Hale Limited, invested a further £0.6 million in 7 qualifying companies during the period. The Fair Value of qualifying investments at 31 August 2011 was £3.5 million invested in 25 AIM companies and 2 unquoted companies (Mexican Grill Ltd, IS E&P/NV Ltd), the balance was held in non-qualifying AIM stocks and Gilts.
A final dividend for the year ended 28 February 2011 of 3 pence was paid on 27 July 2011.
An interim dividend of _ pence will be paid on ______ 2011, with an Ex date of _____ 2011 and record date of ______ 2011. A final dividend will be considered at the year end.
We are able to maintain our policy of offering our shareholders an efficient exit route through the buyback scheme. No shares were repurchased during the six month period ending 31 August 2011.
The Offer closed on 8 March 2011 and since commencement on 20 March 2010, the Offer resulted in funds being received of £2 million and 1.8 million shares were issued in respect of Hargreave Hale AIM VCT 2 plc.
On the 9 March 2011 a new joint offer for subscription of Ordinary Shares was opened to raise approximately £2.65 million, in aggregate, in New Ordinary Shares for Hargreave Hale AIM VCT 1 plc and Hargreave Hale AIM VCT 2 plc. The Offer resulted in funds being received of £0.45 million and 0.4 million shares have been issued for Hargreave Hale AIM VCT 2 plc. The offer closed on the 29 July 2011.
The Company's daily share price can be found on various financial websites under the EPIC code 'HHVT', or on our own dedicated website at www.hargreave-hale.co.uk/fund-management/venture-capital-trusts/hargreave-hale-aim-vct-2/share-price-and-nav/
David Hurst-Brown Chairman
Date:
The US debt-ceiling negotiation, its subsequent downgrade and further deterioration in the European sovereign debt crisis have weighed heavily on equity markets, particularly when viewed alongside the stream of global weak economic data and subsequent downgrades to economic forecasts. With inflationary pressures beginning to recede and key central banks promising or considering loose monetary policy for an extended period, markets have returned to idea of further quantitative easing as we head into 2012. The FTSE 100 Index has slipped 10.0% in the first half whilst the FTSE AIM All-Share Index dropped 17.0%
In H1 of this financial year, the NAV declined from 107.92 to 93.84. A dividend of 3 pence was distributed in July, taking the net loss for the period to 11.08 pence per share (-10.3%). Total returned since launch fell from 123.92 pence to 112.84 pence. The losses in our portfolio within the period were largely unrealised and totalled -£0.66m, of which -£0.41m was attributable to the qualifying portfolio.
We have made further selective qualifying investments in the financial year to date, adding Ideagen (previously Datum, content management and workflow software), Futura Medical (sexual healthcare pharmaceuticals), Indeed (online property conveyancing service), IS E&P/NV (oil and gas exploration), Microsaic (mass spectrometry) and Myclex (clean water technology). Alterian has become non-qualifying. We ended the first half with 27 qualifying investments. Generally speaking, the flow of potential investments has been strong although it is hard to gauge to what extent recent events will weigh on deal flow since the turmoil coincided with the traditionally quiet month of August. Either way, the VCT remains comfortably through the HMRC defined investment test and ended the period at 84% invested.
After a strong second half last year, the first half of this financial year has appeared challenging for the portfolio across qualifying and non-qualifying investments. Net unrealised losses in the qualifying portfolio totalled £0.41m, equivalent to 6.09 pence per share, with 15 of 27 investments losing ground while 9 increased in value and 3 were unchanged. Lombard Risk was the best performer (1.26 pence per share) with a 76% increase in the share price over the first half following a better than expected trading update, solid full-year results and a significant contract win. Photonstar, a maker of smart LED lighting systems, gained 113% (0.36 pence per share), after the full year results supported the view that a credible turnaround was under way, reinforced by news that the company had secured a substantial exclusive supply agreement and positive half-year trading update. Hardide (-1.67 pence per share), Intercede (-1.13 pence per shares), Lidco (-0.98 pence per share) and Electric Word (-0.95 pence per share) were the biggest underperformers. Of these, only Electric Word reported difficult trading. Intercede pared its gains after the company indicated that it would invest in future growth at the expense of short-term profitability whilst Lidco continues to meet market expectations.
Performance in non-qualifying equity investment was disappointing with a loss of 3.69 pence per share unrealised and realised, with Cove (-0.47 pence per share), Egdon Resources (-0.46 pence per share) and Maxima (-0.40 pence per share) leading the fall. Of these, only Maxima released a disappointing update.
We have continued with our strategy of non-qualifying equity investments. We've continued to gradually reduce our weighting to non-qualifying equities in anticipation of weaker markets, down from 19% at the start of the calendar year to 13% by the end of August. Cash increased to £1.16m whilst our fixed income exposure remained static at £0.9m. In total, 32% of the NAV is held in cash or bonds.
Date:
| For the six month period to | ||||
|---|---|---|---|---|
| 31 August 2011 (unaudited) | ||||
| Revenue | Capital | Total | ||
| £000 | £000 | £000 | ||
| Realised gains/(losses) on investments | - | (5) | (5) | |
| Unrealised gains/(losses) on investments | - | (634) | (634) | |
| Income | 33 | - | 33 | |
| ----------- 33 |
----------- (639) |
----------- (606) |
||
| Management fee | (4) | (11) | (15) | |
| Other expenses | (113) | - | (113) | |
| ----------- (117) |
----------- (11) |
----------- (128) |
||
| Profit/(loss) before taxation | ----------- (84) |
----------- (650) |
----------- (734) |
|
| Taxation | - | - | - | |
| ----------- (84) |
----------- (650) |
----------- (734) |
||
| Profit/(loss) after taxation | ----------- | ----------- | ----------- | |
| Earnings/(loss) per share (Note 2) | (1.27)p | (9.79)p | (11.06)p |
The total column of this statement is the income statement of the Company. All revenue and capital items in the above statement derive from continuing operations.
| For the six month period to | ||||
|---|---|---|---|---|
| 31 August 2010 (unaudited) | ||||
| Revenue | Capital | Total | ||
| £000 | £000 | £000 | ||
| Realised gains on investments | - | 17 | 17 | |
| Unrealised losses on investments | - | (367) | (367) | |
| Income | 25 | - | 25 | |
| ----------- 25 |
----------- (350) |
----------- (325) |
||
| Management fee | (6) | (17) | (23) | |
| Other expenses | (80) | - | (80) | |
| ----------- (86) |
----------- (17) |
----------- (103) |
||
| Profit/(loss) before taxation | ----------- (61) |
----------- (367) |
----------- (428) |
|
| Taxation | - | - | - | |
| Profit/(loss) after taxation | ----------- (61) |
----------- (367) |
----------- (428) |
|
| ----------- | ----------- | ----------- | ||
| Earnings/(loss) per share (Note 2) | (1.13)p | (6.79)p | (7.92)p |
The total column of this statement is the income statement of the Company. All revenue and capital items in the above statement derive from continuing operations.
| 31 August | 31 August | |
|---|---|---|
| 2011 | 2010 | |
| (unaudited) | (unaudited) | |
| £000 | £000 | |
| Fixed assets | ||
| Investments | 5,160 | 4,294 |
| Current assets | ----------- | ----------- |
| Prepayments and accrued income | 25 | 98 |
| Cash at bank and on deposit | 1,160 | 825 |
| ----------- 1,185 |
----------- 923 |
|
| Creditors: amounts falling due within one year | ||
| Accruals and deferred income | (41) | (49) |
| Net current assets | ----------- 1,144 |
----------- 874 |
| Net assets | ----------- 6,304 |
----------- 5,168 |
| ----------- | ----------- | |
| Capital and Reserves | ||
| Share capital redemption reserve | 1 | 1 |
| Called up share capital | 67 | 56 |
| Capital reserve - realised | 349 | (30) |
| Capital reserve - unrealised | 93 | (61) |
| Special reserve | 3,774 | 5,314 |
| Share Premium | 2,351 | - |
| Revenue reserve | (331) | (112) |
| Equity shareholders' funds | ----------- 6,304 |
----------- 5,168 |
| Net asset value per share (Note 4) | ----------- 93.84p |
----------- 92.97p |
| 2011 £000 |
2010 £000 |
|
|---|---|---|
| Profit/(loss) on ordinary activities before taxation | (725) | (428) |
| Realised (gains)/losses on investments | (5) | (17) |
| Unrealised (profit)/losses on investments | 634 | 367 |
| Decrease/(Increase) in debtors | (1) | (35) |
| (Decrease)/Increase in creditors | (27) | 1 |
| Net cash (outflow)/inflow from operating activities | ----------- (124) |
----------- (112) |
| Financial investment: | ||
| Purchase of investments | (1,268) | (1,123) |
| Sale of investments | 548 | 929 |
| Net financial investment | ----------- (720) |
----------- (194) |
| Dividends paid | (202) | (111) |
| Cash inflow before management of liquid resources | ----------- (1,046) |
----------- (417) |
| Financing | ----------- | ----------- |
| Purchase of shares for cancellation | - | - |
| Net Proceeds from issue of share capital | 1,086 | 1,102 |
| Net financing | ----------- 1,086 |
----------- 1,102 |
| Increase/(Decrease) in cash | ----------- 40 |
----------- 685 |
| ----------- | ----------- |
| Share | Capital Capital Redemption |
Capital Reserve |
Capital Reserve |
Special Reserve |
Share Premium |
Revenue Reserve |
Total | |
|---|---|---|---|---|---|---|---|---|
| Reserve | Realised | Unrealised | ||||||
| £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
| At beginning of period | 57 | 1 | 366 | 727 | 3,975 | 1,275 | (247) | 6,154 |
| Realised gains on investments |
- | - | (5) | - | - | - | - | (5) |
| Unrealised profit on investments |
- | - | - | (634) | - | - | - | (634) |
| Management fee charged to capital |
- | - | (12) | - | - | - | - | (12) |
| Equity dividends paid | - | - | - | - | (202) | - | - | (202) |
| Shares repurchased for cancellation |
- | - | - | - | - | - | - | - |
| Profit after taxation for the period |
- | - | - | - | - | - | (84) | (84) |
| Subscription | 11 ---------- |
- ----------- |
- ---------- |
- ----------- |
- ----------- |
1,076 ----------- |
- ----------- |
1,087 ---------- |
| At end of period | 68 ---------- |
1 ----------- |
349 ---------- |
93 ----------- |
3,773 ----------- |
2,351 ----------- |
(331) ----------- |
6,304 ---------- |
| Share | Capital | Capital | Capital | Special | Share | Revenue | ||
|---|---|---|---|---|---|---|---|---|
| Capital Redemption | Reserve | Reserve | Reserve | Premium | Reserve | Total | ||
| Reserve | Realised | Unrealised | ||||||
| £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
| At beginning of period | 45 | - | 81 | 306 | 4,223 | - | (51) | 4,604 |
| Realised gains on investments |
- | - | 17 | - | - | - | - | 17 |
| Unrealised gains on investments |
- | - | - | (367) | - | - | - | (367) |
| Management fee charged to capital |
- | - | (17) | - | - | - | - | (17) |
| Equity dividends paid | - | - | (111) | - | - | - | - | (111) |
| Shares repurchased for cancellation |
- | 1 | - | - | - | - | - | 1 |
| Subscriptions | 11 | - | - | - | 1,091 | - | - | 1,102 |
| Profit after taxation for the period |
- ---------- |
- ----------- |
- ---------- |
- ----------- |
- ----------- |
- ----------- |
(61) ----------- |
(61) ---------- |
| At end of period | 56 ---------- |
1 ----------- |
(30) ---------- |
(61) ----------- |
5,314 ----------- |
- ----------- |
(112) ----------- |
5,168 ---------- |
| Book Cost | Valuation | Valuation | |
|---|---|---|---|
| Qualifying investments | £000 | £000 | % |
| Animalcare Group plc | 100 | 291 | 5.6 |
| Mexican Grill Ltd (A Pref) | 277 | 277 | 5.4 |
| EKF Diagnostic | 150 | 243 | 4.7 |
| Advanced Computer Software plc | 100 | 224 | 4.3 |
| Lidco Group plc | 147 | 204 | 4.0 |
| Lombard Risk Management plc | 104 | 196 | 3.8 |
| Hardide plc | 113 | 188 | 3.6 |
| Omega Diagnostics Group plc | 200 | 167 | 3.2 |
| My Celx | 150 | 154 | 3.0 |
| Intercede Group plc | 96 | 151 | 2.9 |
| Electric Word plc | 185 | 140 | 2.7 |
| Fulcrum Utilities Services Ltd | 100 | 135 | 2.6 |
| In -Deed |
117 | 128 | 2.5 |
| Marwyn Capital II Ltd | 100 | 115 | 2.2 |
| Reneuron Group plc | 75 | 113 | 2.2 |
| Ideagen | 100 | 111 | 2.2 |
| Microsaic | 117 | 99 | 1.9 |
| Tristel plc | 100 | 98 | 1.9 |
| Plastics Capital plc | 100 | 83 | 1.6 |
| Futura Medical | 75 | 76 | 1.5 |
| Corac | 100 | 65 | 1.3 |
| Photonstar | 97 | 46 | 0.9 |
| Synchronica plc | 100 | 31 | 0.6 |
| Mexican Grill Ltd (Ord ) |
31 | 31 | 0.6 |
| Saville Holdings plc | 151 | 30 | 0.6 |
| IS E&P | 25 | 25 | 0.5 |
| IS NV | 25 | 25 | 0.5 |
| Optare plc | 116 | 11 | 0.2 |
| Image Scan Holdings plc | 93 | 9 | 0.2 |
| Total qualifying investments | -------- 3,242 |
-------- 3,462 |
-------- 67.1 |
| Non -Qualifying investments |
Book Cost £000 |
Valuation £000 |
Valuation % |
|---|---|---|---|
| UK Treasury 2.25% 2014 | 294 | 311 | 6.0 |
| Total – UK gilts |
-------- 294 |
-------- 311 |
-------- 6.0 |
| Nationwide 3.75% 2011 |
-------- 254 |
-------- 25 2 |
-------- 4.9 |
| Scot Amicable 8.5% 2049 | 15 4 |
15 2 |
2.9 |
| Nationwide 7.971% 2049 | 145 | 14 4 |
2.8 |
| Total – UK corporate bonds |
-------- 553 |
-------- 548 |
-------- 10.6 |
| Craneware | -------- 83 |
-------- 98 |
-------- 1.9 |
| Sinclair IS Pharma | 100 | 92 | 1.8 |
| Instem Life | 53 | 66 | 1.3 |
| Egdon Resources plc | 80 | 61 | 1.2 |
| Anglo Pacific plc | 67 | 59 | 1.2 |
| TMO | 50 | 50 | 1.0 |
| GW Pharma | 52 | 50 | 1.0 |
| XP Power | 64 | 47 | 0.9 |
| Prophotonix | 40 | 43 | 0.8 |
| Tantalus | 37 | 40 | 0.8 |
| Skill P&L | 50 | 34 | 0.7 |
| Agriferma Brazil Ltd | 26 | 32 | 0.6 |
| Cohort | 20 | 22 | 0.4 |
| Encore Oil | 30 | 22 | 0.4 |
| OMG | 31 | 19 | 0.4 |
| In -Deed |
17 | 19 | 0.4 |
| Richoux Group plc | 35 | 18 | 0.3 |
| Pressure Technologies | 19 | 15 | 0.3 |
| Westmount Energy Ltd | 16 | 11 | 0.2 |
| Optare plc | 12 | 10 | 0.2 |
| Maxima | 36 | 7 | 0.1 |
| Acta Spa | 41 | 7 | 0.1 |
| Fulcrum Utilities Services Ltd | 5 | 4 | 0.1 |
| Marwin Value Inv Ltd B |
5 | 4 | 0.1 |
| Animal Care | 3 | 3 | 0.1 |
| Lombard Risk | 3 | 2 | 0.0 |
| Marwyn Capital II | 1 | 1 | 0.0 |
| Intercede | 2 | 1 | 0.0 |
| Omega Diagnostics | 2 | 1 | 0.0 |
| Futura Medical | 1 | 1 | 0.0 |
| Electric Word | 1 | 1 | 0.0 |
| Microsaic | 1 | 1 | 0.0 |
| Corac | 1 | 0 | 0.0 |
| Photonstar | 2 | 0 | 0.0 |
| EKF Diagnostic | 0 | 0 | 0.0 |
| Hardide | 0 -------- |
0 -------- |
0.0 -------- |
| Total – non -qualifying equities |
984 -------- |
840 -------- |
16.3 -------- |
| Total – non -qualifying investments |
1,831 | 1,699 | 26.9 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.